STRATA Skin Sciences (SSKN) Liabilities and Shareholders Equity (2010 - 2025)

STRATA Skin Sciences has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $30.5 million for Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $30.5 million, down 12.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $123.8 million (down 18.73% YoY), and the FY2025 annual result was $30.5 million, down 12.62% from the prior year.
• Liabilities and Shareholders Equity came in at $30.5 million for Q4 2025 at STRATA Skin Sciences, down from $30.7 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $55.2 million in Q2 2023 to a low of $29.5 million in Q2 2025.
• The 5-year median for Liabilities and Shareholders Equity is $45.4 million (2021), against an average of $43.4 million.
• Across the five-year window, Liabilities and Shareholders Equity grew 20.14% in 2022 and slipped 29.79% in 2024, its largest moves.
• STRATA Skin Sciences' Liabilities and Shareholders Equity stood at $46.6 million in 2021, then rose by 12.19% to $52.3 million in 2022, then retreated by 19.62% to $42.0 million in 2023, then decreased by 16.87% to $34.9 million in 2024, then slipped by 12.62% to $30.5 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $30.5 million (Q4 2025), $30.7 million (Q3 2025), and $29.5 million (Q2 2025), per Business Quant data.